Differential participation of protein kinase C and Rho kinase in α1-adrenoceptor mediated contraction in rat arteries

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 10, 2004, Pages 895-902

  Mueed, Irem ^a   Bains, Perminder ^a   Zhang, Lili ^a   MacLeod, Kathleen M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

1 adrenoceptors; Phenylephrine; Protein kinase C; Rho kinase; Vascular smooth muscle

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1D ADRENERGIC RECEPTOR; CPI 17; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; PHENYLEPHRINE; PHORBOL DIBUTYRATE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATED PROTEIN PHOSPHATASE INHIBITOR OF 17KDA; PROTEIN KINASE C INHIBITOR; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTERY; ARTERY CONSTRICTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESPONSE; MALE; MEDIAN SACRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; VASOCONSTRICTION;

EID: 13544276940     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-086     Document Type: Conference Paper

References (42)

1. Barandier, C., Ming, X.F., Rusconi, S., and Yang, Z. 2003. PKC is required for activation of ROCK by RhoA in human endothelial cells. Biochem. Biophys. Res. Commun. 304: 714-719.
2. Buckner, S.A., Oheim, K.W., Morse, P.A., Knepper, S.M., and Hancock, A.A. 1996. Alpha 1-adrenoceptor-induced contractility in rat aorta is mediated by the alpha 1D subtype. Eur. J. Pharmacol. 297: 241-248.
3. Cheung, Y.D., Feltham, I., Thompson, P., and Triggle, C.R. 1990. Alpha-adrenoceptor activation of polyphosphoinositide hydrolysis in the rat tail artery. Biochem. Pharmacol. 40(11): 2425-2432.
4. Davies, S.P., Reddy, H., Caivano, M., and Cohen, P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351: 95-105.
5. Dubyak, G.R., and Kertesy, S.B. 1997. Inhibition of GTP gamma S-dependent phospholipase D and Rho membrane association by calphostin is independent of protein kinase C catalytic activity. Arch. Biochem. Biophys. 341: 129-139.
6. Eto, M., Karginov, A., and Brautigan, D.L. 1999. A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes. Biochemistry, 38: 16 952-16 957.
7. Eto, M., Kitazawa, T., Yazawa, M., Mukai, H., Ono, Y., and Brautigan, D.L. 2001. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J. Biol. Chem. 276: 29 072-29 078.
8. Faure, C., Pimoule, C., Arbilla, S., Langer, S.Z., and Graham, D. 1994. Expression of alpha 1-adrenoceptor subtypes in rat tissues: implications for alpha 1-adrenoceptor classification. Eur. J. Pharmacol. 268: 141-149.
9. 2+- independent activation of the endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 96: 1123-1128.
10. Fukata, Y., Amano, M., and Kaibuchi, K. 2001. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22: 32-39.
11. 1D- adrenoceptors in rat aorta. J. Pharmacol. Exp. Ther. 295: 810-817.
12. Gisbert, R., Madrero, Y., Sabino, V., Noguera, M.A., Ivorra, M.D., and D'Ocon, P. 2003. Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study. Br. J. Pharmacol. 138: 359-368.
13. Guimaraes, S., and Moura, D. 2001. Vascular adrenoceptors: an update. Pharmacol. Rev. 53: 319-356.
14. Hippenstiel, S., Kratz, T., Krull, M., Seybold, J., Eichel-Streiber, C., and Suttorp, N. 1998. Rho protein inhibition blocks protein kinase C translocation and activation. Biochem. Biophys. Res. Commun. 245: 830-834.
15. Hussain, M.B., and Marshall, I. 1997. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery. Br. J. Pharmacol. 122: 849-858.
16. 2α-induced contraction of rabbit aortae. J. Physiol. 546: 823-836.
17. Kamada, Y., Qadota, H., Python, C.P., Anraku, Y., Ohya, Y., and Levin, D.E. 1996. Activation of yeast protein kinase C by Rho1 GTPase. J. Biol. Chem. 271: 9193-9196.
18. Knepper, S.M., Buckner, S.A., Brune, M.E., DeBernardis, J.F., Meyer, M.D., and Hancock, A.A. 1995. A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype. J. Pharmacol. Exp. Ther. 274: 97-103.
19. Lachnit, W.G., Tran, A.M., Clarke, D.E., and Ford, A.P. 1997. Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br. J. Pharmacol. 120: 819-826.
20. Lee, Y.H., Kim, I., Laporte, R., and Morgan, K.G. 1999. Isozyme-specific inhibitors of protein kinase C translocation: effects on contractility of single permeabilized vascular muscle cells of the ferret. J. Physiol. 517: 709-720.
21. Li, L., Eto, M., Lee, M.R., Morita, F., Yazawa, M., and Kitazawa, T. 1998. Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. J. Physiol. 508: 871-881.
22. 2+ handling of human small arteries. Am. J. Physiol. Heart Circ. Physiol. 279: H1228-H1238.
23. Nozu, F., Tsunoda, Y., Ibitayo, A.I., Bitar, K.N., and Owyang, C. 1999. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini. Am. J. Physiol. 276: G915-G923.
24. 1A-adrenergic receptor-stimulated activation of phospholipase D in rat-1 cells, independent of PKC. J. Pharmacol. Exp. Ther. 303: 1206-1215.
25. Piascik, M.T., Hrometz, S.L., Edelmann, S.E., Guarino, R.D., Hadley, R.W., and Dale Brown, R. 1997. Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and other subtypes to vascular smooth muscle contraction: Analysis with selective ligands and antisense oligonucleotides. J. Pharmacol. Exp. Ther. 283: 854-868.
26. Schwinn, D.A., Johnston, G.I., Page, S.O., Mosley, M.J., Wilson, K.H., Worman, N.P. et al. 1995. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J. Pharmacol. Exp. Ther. 272: 134-142.
27. Scofield, M.A., Liu, F., Abel, P.W., and Jeffries, W.B. 1995. Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J. Pharmacol. Exp. Ther. 275: 1035-1042.
28. Seasholtz, T.M., Majumdar, M., and Brown, J.H. 1999. Rho as a mediator of G protein-coupled receptor signaling. Mol. Pharmacol. 55: 949-956.
29. Seko, T., Ito, M., Kureishi, Y., Okamoto, R., Moriki, N., Onishi, K. et al. 2003. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ. Res. 92: 411-418.
30. Senba, S., Eto, M., and Yazawa, M. 1999. Identification of trimeric myosin phosphatase (PP1M) as a target for a novel PKC-potentiated protein phosphatase-1 inhibitory protein (CPI-17) in porcine aorta smooth muscle. J. Biochem. (Tokyo), 125: 354-362.
31. 2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C. Circ. Res. 91: 112-119.
32. Somlyo, A.P., Wu, X., Walker, L.A., and Somlyo, A.V. 1999. Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev. Physiol. Biochem. Pharmacol. 134: 201-234.
33. 2+ oscillations in isolated rat aorta: role of protein kinase C. J. Smooth Muscle Res. 36: 205-218.
34. Taguchi, K., Yang, M., Goepel, M., and Michel, M.C. 1998. Comparison of human alpha 1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways. Naunyn-Schmiedeberg's Arch. Pharmacol. 357: 100-110.
35. Theroux, T.L., Esbenshade, T.A., Peavy, R.D., and Minneman, K.P. 1996. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol. Pharmacol. 50: 1376-1387.
36. Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T. et al. 1997. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature, 389: 990-994.
37. 1- adrenoceptor subtypes: functions and signaling. Can. J. Physiol. Pharmacol. 78: 267-292.
38. Vorotnikov, A.V., Krymsky, M.A., and Shirinsky, V.P. 2002. Signal transduction and protein phosphorylation in smooth muscle contraction. Biochemistry (Mosc), 67: 1309-1328.
39. Way, K.J., Chou, E., and King, G.L. 2000. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21: 181-187.
40. Wickman, G., Lan, C., and Vollrath, B. 2003. Functional roles of the Rho/Rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin. Relevance to subarachnoid hemorrhage and vasospasm. Circ. Res. 92: 809-816.
41. 2+ sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J. Physiol. 535(2): 553-564.
42. Zhong, H., and Minneman, K.P. 1999. Alpha1-adrenoceptor subtypes. Eur. J. Pharmacol. 375: 261-276.